JP Morgan Initiates Neurocrine Biosciences With Overweight
March 19, 2015 at 09:18 AM EDT
Analysts at JP Morgan initiated coverage on Neurocrine Biosciences Inc. (NASDAQ: NBIX) with a Overweight rating. The target price for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.